LivaNova PLC (LIVN)

Name: LivaNova PLC (LIVN) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: LivaNova PLC (LIVN)

Stock Card

$79.81

$-0.51 (-0.63%)

As on 31-Aug-2026 16:04EDT

Market cap

$4,425 Mln

Revenue (TTM)

$1,472 Mln

P/E Ratio

23.7

P/B Ratio

3.3

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

LivaNova (LIVN) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 77.28 High: 80.15

52 Week Range

Low: 48.82 High: 85.76

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.2 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

20.6
Debt to Equity

0.2
Book Value

$--
EPS

$3.4
Face value

--
Shares outstanding

55,093,507

10 Years Aggregate

CFO

$449.20 Mln

EBITDA

$1,200.67 Mln

Net Profit

$-952.22 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
LivaNova (LIVN)	29.7	-1.5	8.1	41.6	12.5	-0.6	2.9
BSE Sensex^*	-9.0	-1.4	3.0	-3.5	5.9	6.0	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 31-Aug-2026 | *As on 01-Sep-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021	2020	2019
LivaNova (LIVN)	32.9	-6.8	-36.5	32.0	-12.2	-17.5
S&P Small-Cap 600	4.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About LivaNova (LIVN)

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides... cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom. Read more

Chief Financial Officer

Mr. Alex Shvartsburg
Chief Financial Officer

Mr. Alex Shvartsburg C.M.A.
Headquarters

Gloucester
Website

https://www.livanova.com

FAQs for LivaNova (LIVN)

What is the current share price of LivaNova PLC (LIVN) Today?

The share price of LivaNova PLC (LIVN) is $79.81 (NASDAQ) as of 31-Aug-2026 16:04 EDT. LivaNova PLC (LIVN) has given a return of 12.46% in the last 3 years.